Keyphrases
Myogenic Progenitors
75%
Stem Cell-derived
59%
Pluripotent Stem Cells
49%
Embryonic Stem Cells
48%
Pax7
46%
Muscular Dystrophy
42%
Induced Pluripotent Stem Cells (iPSCs)
41%
Engraftment
36%
Pax3
31%
Transplantation
28%
Endoglin
27%
Satellite Cells
26%
Myogenic
26%
Myotubes
25%
Hematopoietic Stem Cells
24%
Cell-based
23%
Skeletal muscle
23%
Stem Cells
19%
Human Pluripotent Stem Cells (hPSCs)
19%
Skeletal muscle Cells
18%
Fukutin-related Protein
17%
Myofiber
17%
Embryoid Body
15%
Dystrophic Mice
14%
Dystroglycan
14%
Dystrophin
14%
Duchenne muscular Dystrophy
13%
Therapeutic Potential
13%
Skeletal muscle Regeneration
12%
Cell Transplantation
12%
Facioscapulohumeral muscular Dystrophy
12%
Therapeutic Use
12%
DUX4
12%
Muscle Regeneration
12%
Hematopoiesis
11%
Cell Therapy
11%
Disease Modeling
11%
Hematopoietic Development
10%
Donor-derived
10%
Cell Population
10%
Mesenchymal Stem Cells
10%
Sickle Cell Disease
10%
Hemangioblast
10%
Erythroid
10%
Mouse Pluripotent Stem Cells
9%
Paraxial Mesoderm
9%
Teratoma
9%
Muscle Disease
9%
Lineage-specific
9%
Myogenic Cells
9%
Biochemistry, Genetics and Molecular Biology
Stem Cell
100%
Mouse
60%
Skeletal Muscle
45%
Induced Pluripotent Stem Cell
44%
Embryonic Stem Cell
36%
Endoglin
27%
PAX7
22%
Maturation
20%
Fukutin-Related Protein
18%
Hematopoiesis
18%
Muscle Regeneration
18%
Embryoid Body
17%
Mouse Model
16%
Myogenesis
14%
Dystroglycan
14%
Dystrophin
13%
Precursor
13%
DUX4
12%
Paraxial Mesoderm
12%
Cardiac Muscle Cell
11%
Mesoderm
10%
Cell Transplantation
10%
Embryogenesis
10%
Hemangioblast
10%
Hematopoietic Stem Cell
9%
Myeloid
9%
Burst Forming Unit
9%
Progenitor Cell
9%
Transcription Factors
9%
Teratoma
8%
Transgene
8%
Muscle Contractility
8%
Disease Modeling
7%
Glycosylation
7%
Enhancer Region
7%
Muscle Function
7%
Transforming Growth Factor
6%
Signal Transduction
6%
Stem Cell Transplantation
6%
Epigenetics
6%
Mutant Protein
6%
Eicosanoid Receptor
6%
RNA
6%
Heavy Meromyosin
5%
Gene Expression
5%
CRISPR/Cas9
5%
Stem Cell Line
5%
Angiogenesis
5%
Transcription
5%
Gene Expression Profiling
5%